Reports
Sale
Global Heart Valve Devices Market Size, Share, Trends, Report: By Product Type: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Valves; By Treatment: Open Surgery, Minimally Invasive Surgery (MIS); By End User: Hospitals, Speciality Clinics, Home Healthcare, Others; Regional Analysis; Competitive Landscape; 2024-2032
Global Heart Valve Devices Market Outlook
The global heart valve devices market size was valued at USD 10.3 billion in 2023, driven by the increasing incidence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 12.9% during the forecast period of 2024-2032 to achieve a value of USD 30.7 billion by 2032.
Heart Valve Devices: Introduction
A heart valve is a one-way valve that allows blood to pass through the heart only in one direction. In a mammalian heart, the four valves are frequently represented to show the blood flow pattern through the heart. Depending on the blood pressure differences on each side, a heart valve may open or close as needed. The valves occasionally fail to open or seal precisely. This happens when the blood flow from the heart to the rest of the body is obstructed. It is also known as heart valve disease, and the course of treatment for this condition varies on the heart valve in question as well as the type and degree of the disease.
Global Heart Valve Devices Market Analysis
The global market for heart valve devices is experiencing a surge in growth driven by several key trends. The key trends in the market include increased investments by the key players in the market. For example, Xeltis' successful fundraising is propelling the development of advanced restorative cardiovascular devices. Xeltis, a pioneering medical technology company, is a leader in heart valve replacement and vascular therapies, with the aim of providing patients worldwide access to cutting-edge treatments.
Furthermore, increased research and development activities focused on finding optimal treatments for cardiovascular diseases are significantly proeplling the global heart valve replacement market growth as well. The newly launched products by the key players in the market are also enhancing the market value. For example, minimally invasive procedures like the EVOQUE tricuspid valve replacement system shorten patient recovery times and improve outcomes. This investigational device offers a less invasive alternative to open-heart surgery, showcasing the relentless pursuit of innovative solutions in cardiovascular care.
Additionally, the increased number of clinical trials conducted by key players is further fueling the market growth. For example, Abbott highlights the commitment to advancing treatment options. Abbott's successful clinical trial involving tricuspid valve clipping demonstrates the continuous efforts to enhance patient outcomes and reduce risks.
In conclusion, these market trends collectively contribute to the robust global heart valve devices market growth.
Global Heart Valve Devices Market Segmentations
Market Breakup by Product Type
- Mechanical Heart Valves
- Biological Heart Valves
- Transcatheter Valves
Market Breakup by Treatment
- Open Surgery
- Minimally Invasive Surgery (MIS)
Market Breakup by End User
- Hospitals
- Speciality Clinics
- Home Healthcare
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Heart Valve Devices Market Overview
The market is experiencing robust growth driven by the rising number of various heart diseases worldwide, with coronary heart disease being a significant contributor to cardiovascular-related mortality. This prevalence emphasizes the growing demand for advanced heart valve devices to address these conditions. Additionally, there is a substantial shift in preference toward minimally invasive treatment strategies, particularly for complex heart disorders like mitral regurgitation. This shift aligns with the increasing advancements in technology, leading to the development of exceptional products in the market. Continuous innovation in valve technologies by medical device manufacturers is creating new opportunities for the market, further propelling the global heart valve devices market growth.
Geographically, North America is currently leading the regional market and is expected to lead the market in the coming years as well. The region has the presence of a robust healthcare system and key market players. The market is further driven by increased awareness among people regarding the benefits of minimally invasive procedures and robot-assisted surgeries. These drivers collectively contribute to the thriving global heart valve devices market.
Global Heart Valve Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AgaMatrix Holdings LLC
- Coloplast Corp
- 3M Co.
- Cardinal Health
- ConvaTec Inc.
- B. Braun Melsungen AG
- SMITH & NEPHEW
- Convatec Group PLC
- Medline Industries
- Integra Lifesciences Corp.
- Mckesson Corporation
- Dermarite Industries, LLC
- Amerx Health Care Corp
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Treatment |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Heart Valve Devices Market Overview
3.1 Global Heart Valve Devices Market Historical Value (2017-2023)
3.2 Global Heart Valve Devices Market Forecast Value (2023-2031)
4 Global Heart Valve Devices Market Landscape
4.1 Global Heart Valve Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Heart Valve Devices Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Heart Valve Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Heart Valve Devices Market Segmentation
6.1 Global Heart Valve Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Mechanical Heart Valves
6.1.3 Biological Heart Valves
6.1.4 Transcatheter Valves
6.2 Global Heart Valve Devices Market by Treatment
6.2.1 Market Overview
6.2.2 Open Surgery
6.2.3 Minimally Invasive Surgery (MIS)
6.3 Global Heart Valve Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Speciality Clinics
6.3.4 Home Healthcare
6.3.5 Others
6.4 Global Heart Valve Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Heart Valve Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Heart Valve Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Heart Valve Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Heart Valve Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Heart Valve Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 AgaMatrix Holdings LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Coloplast Corp
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 3M Co.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ConvaTec Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 SMITH & NEPHEW
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Convatec Group PLC
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Medline Industries
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Integra Lifesciences Corp.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Mckesson Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Dermarite Industries, LLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Amerx Health Care Corp.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Heart Valve Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 10.3 billion in 2023, driven by increased advancements.
The market is anticipated to grow at a CAGR of 12.9% during the forecast period of 2024-2032 and is likely to reach a market value of USD 30.7 billion by 2032.
The increasing incidence of cardiovascular diseases is a major factor driving the market growth.
Increasing heavy investments by the key players is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various product types include mechanical heart valves, biological heart valves, and transcatheter valves.
Heart valve devices are used in open surgery and minimally invasive surgery (MIS).
End users in the market are hospitals, speciality clinics, and home healthcare, among others.
Key players involved in the market are AgaMatrix Holdings LLC, Coloplast Corp, 3M Co., Cardinal Health, ConvaTec Inc., B. Braun Melsungen AG, SMITH & NEPHEW, Convatec Group PLC, Medline Industries, Integra Lifesciences Corp., Dermarite Industries, LLC, Amerx Health Care Corp., and Mckesson Corporation.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER